Effects of Adjunctive Lacosamide on Mood States and Quality of Life (QOL) in Patients With Epilepsy

NCT01296880 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2015-12-24

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of lacosamide on mood and quality of life in people with epilepsy.

Conditions

Sponsors & Collaborators

  • UCB Pharma

    collaborator INDUSTRY
  • State University of New York - Downstate Medical Center

    lead OTHER

Principal Investigators

  • Arthur C Grant, MD, PhD · State University of New York - Downstate Medical Center

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01296880 on ClinicalTrials.gov